FWK-19551-94792
5 vaccinations
28 coded responses
63 check-ins
28 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 017 / MA
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Registered in v-safe
-
2021-01-27
Dose 1 — Moderna
- 2021-01-27
-
2021-01-28
Survey response — days 1–6 daily, dose 1MedDRA: Musculoskeletal stiffness — Feeling: Good · Site: Pain, SwellingFree text: Shoulder(inj site side) upper back and neck stiffnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Survey response — days 1–6 daily, dose 1MedDRA: Influenza like illness — Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness, NauseaFree text: Flu-like feelingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Survey response — days 1–6 daily, dose 1MedDRA: Dermatitis, Rash papular — Feeling: Good · Site: Swelling · Rash, not including the immediate area around the injection siteFree text: Raised rash on chin. Looks like dermatitis.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
-
2021-02-10
Survey response — day 14, dose 1MedDRA: Arthralgia, Injection site pain, Injection site pruritus, Injection site rash, Injection site swelling, Rash papular — Feeling: GoodFree text: Itching at inj site on Day 8. Immediate raised, red rash 3x 4, after scratching. W/in 10 min, swelling and soreness at inj site same as Day 1. Shoulder soreness developed that night lasting 4 days. Itch/swell again on Day 9. Rash for 4 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-17
-
2021-02-24
Dose 2 — Moderna
- 2021-02-24
-
2021-02-25
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite, Dizziness — Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesFree text: Dizziness, lack of appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Survey response — days 1–6 daily, dose 2MedDRA: Chills, Pyrexia — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Be unable to do your normal daily activitiesFree text: Yesterday afternoon after I submitted my check-in, I developed a fever of 101.5 and chills which lasted about 4 hours, cycling between fever and chills.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · NoneAdult check-in
-
2021-02-28
Survey response — days 1–6 daily, dose 2MedDRA: Heart rate decreased — Feeling: Good · Site: RednessFree text: Sleeping heart rate measured by Apple Watch is approx 10bpm (53-58bpm, avg 56bpm) below normal for past two days. Same for road cycling and tennis.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-01
Survey response — days 1–6 daily, dose 2MedDRA: Heart rate decreased — Feeling: GoodFree text: Sleeping heart rate measured by Apple Watch lower than avg at 59bpm. (56-63bpm range)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-02
Survey response — days 1–6 daily, dose 2MedDRA: Heart rate decreased — Feeling: GoodFree text: Sleeping HR still low, avg 57bpm (54-61)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Survey response — day 7, dose 2MedDRA: Unevaluable event — Feeling: GoodFree text: Sleeping HR still 3-4 bpm lower than normal. Tennis and cycling HR 10-15bpm lower than normalMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-10
- 2021-03-19
- 2021-03-24
- 2021-04-02
- 2021-04-07
- 2021-05-26
- 2021-08-25
-
2021-11-04
Dose 3 — Moderna
-
2021-11-05
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness, Fatigue — Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Dizziness, FatigueMedDRA releases: 2024-11 · check-in free text available
-
2021-11-06
Survey response — days 1–6 daily, dose 3MedDRA: Body temperature increased — Feeling: Good · Site: Pain, Redness, Swelling, ItchingFree text: Fever was still at 99.8deg at 9pm yesterday. Normal temp is 97.2-97.6MedDRA releases: 2024-11 · check-in free text available
-
2021-11-07
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness — Feeling: Good · Site: Pain, ItchingFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
- 2021-11-08
- 2021-11-09
-
2021-11-13
Survey response — day 7, dose 3MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2024-11 · check-in free text available
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2021-12-16
- 2022-02-03
- 2022-05-05
-
2022-05-13
Dose 4 — Moderna
-
2022-05-14
Survey response — days 1–6 daily, dose 4MedDRA: Dyspnoea — Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Shortness of breathMedDRA releases: 2024-11 · check-in free text available
-
2022-05-15
Survey response — days 1–6 daily, dose 4MedDRA: Tinnitus — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: TinnitusMedDRA releases: 2024-11 · check-in free text available
-
2022-05-16
Survey response — days 1–6 daily, dose 4MedDRA: Heart rate increased — Feeling: Good · Site: PainFree text: High heart rateMedDRA releases: 2024-11 · check-in free text available
-
2022-05-17
Survey response — days 1–6 daily, dose 4MedDRA: Heart rate increased, Tinnitus — Feeling: GoodFree text: High resting heart rate (20%+) and tinnitusMedDRA releases: 2024-11 · check-in free text available
-
2022-05-18
Survey response — days 1–6 daily, dose 4MedDRA: Heart rate increased, Tinnitus — Feeling: GoodFree text: Tinnitus, High resting heart rate (20%+)MedDRA releases: 2024-11 · check-in free text available
-
2022-05-19
Survey response — days 1–6 daily, dose 4MedDRA: Heart rate increased, Tinnitus — Feeling: GoodFree text: Tinnitus and elevated resting heart rate (20%+)MedDRA releases: 2024-11 · check-in free text available
-
2022-05-20
Survey response — day 7, dose 4MedDRA: Tinnitus, Unevaluable event — Feeling: GoodFree text: Tinnitus, resting heart rate 15%+ normalMedDRA releases: 2024-11 · check-in free text available
- 2022-05-27
- 2022-06-03
- 2022-06-10
- 2022-06-19
- 2022-06-24
- 2022-08-12
-
2022-10-04
Dose 5 — Moderna
-
2022-10-05
Survey response — days 1–6 daily, dose 5MedDRA: Heart rate increased, Tinnitus — Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: Tinnitus, elevated resting heart rate10-15% higher than normalMedDRA releases: 2024-11 · check-in free text available
-
2022-10-07
Survey response — days 1–6 daily, dose 5MedDRA: Heart rate increased, Tinnitus — Feeling: GoodFree text: Elevated resting heart rate15-20% higher than normal, tinnitusMedDRA releases: 2024-11 · check-in free text available
-
2022-10-08
Survey response — days 1–6 daily, dose 5MedDRA: Heart rate increased — Feeling: GoodFree text: Resting heart rate, is not about 10% above normalMedDRA releases: 2024-11 · check-in free text available
-
2022-10-09
Survey response — days 1–6 daily, dose 5MedDRA: Heart rate increased — Feeling: GoodFree text: Resting HR 15% above normalMedDRA releases: 2024-11 · check-in free text available
-
2022-10-13
Survey response — day 7, dose 5MedDRA: Heart rate increased — Feeling: GoodFree text: Resting heart rate still 10-15% above normalMedDRA releases: 2024-11 · check-in free text available
- 2022-10-18
- 2022-10-25
- 2022-11-01
-
2022-11-08
Survey response — day 35, dose 5MedDRA: Fatigue — Feeling: Good · Be unable to do your normal daily activitiesFree text: FatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-11-15
Survey response — day 42, dose 5MedDRA: Fatigue — Feeling: Good · Be unable to do your normal daily activitiesFree text: FatigueMedDRA releases: 2024-11 · check-in free text available
- 2023-01-09
- 2023-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Moderna | |
| 2 | 2021-02-24 | Moderna | |
| 3 | 2021-11-04 | Moderna | No |
| 4 | 2022-05-13 | Moderna | No |
| 5 | 2022-10-04 | Moderna | No |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Shoulder(inj site side) upper back and neck stiffness
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Flu-like feeling
Systemic reaction (other): Raised rash on chin. Looks like dermatitis.
Release 4 — day 14, dose 1
Symptoms: Itching at inj site on Day 8. Immediate raised, red rash 3x 4, after scratching. W/in 10 min, swelling and soreness at inj site same as Day 1. Shoulder soreness developed that night lasting 4 days. Itch/swell again on Day 9. Rash for 4 days
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness, lack of appetite
Systemic reaction (other): Yesterday afternoon after I submitted my check-in, I developed a fever of 101.5 and chills which lasted about 4 hours, cycling between fever and chills.
Systemic reaction (other): Sleeping heart rate measured by Apple Watch is approx 10bpm (53-58bpm, avg 56bpm) below normal for past two days. Same for road cycling and tennis.
Systemic reaction (other): Sleeping heart rate measured by Apple Watch lower than avg at 59bpm. (56-63bpm range)
Systemic reaction (other): Sleeping HR still low, avg 57bpm (54-61)
Release 5 — day 7, dose 2
Systemic reaction (other): Sleeping HR still 3-4 bpm lower than normal. Tennis and cycling HR 10-15bpm lower than normal
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Dizziness, Fatigue
Systemic reaction (other): Fever was still at 99.8deg at 9pm yesterday. Normal temp is 97.2-97.6
Systemic reaction (other): Dizziness
Release 10 — day 7, dose 3
Systemic reaction (other): No
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Shortness of breath
Systemic reaction (other): Tinnitus
Systemic reaction (other): High heart rate
Systemic reaction (other): High resting heart rate (20%+) and tinnitus
Systemic reaction (other): Tinnitus, High resting heart rate (20%+)
Systemic reaction (other): Tinnitus and elevated resting heart rate (20%+)
Release 11 — day 7, dose 4
Systemic reaction (other): Tinnitus, resting heart rate 15%+ normal
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Tinnitus, elevated resting heart rate10-15% higher than normal
Systemic reaction (other): Elevated resting heart rate15-20% higher than normal, tinnitus
Systemic reaction (other): Resting heart rate, is not about 10% above normal
Systemic reaction (other): Resting HR 15% above normal
Release 12 — day 7, dose 5
Systemic reaction (other): Resting heart rate still 10-15% above normal
Release 12 — day 35, dose 5
Symptoms: Fatigue
Release 12 — day 42, dose 5
Symptoms: Fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Rash papular | ✓ | ✓ | ✓ |
| SRO | Body temperature increased | · | · | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Dermatitis | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Heart rate decreased | ✓ | ✓ | ✓ |
| SRO | Heart rate increased | · | · | ✓ |
| SRO | Influenza like illness | ✓ | ✓ | ✓ |
| SRO | Musculoskeletal stiffness | ✓ | ✓ | ✓ |
| SRO | No adverse event | · | · | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
| SRO | Rash papular | ✓ | ✓ | ✓ |
| SRO | Tinnitus | · | · | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release